Howard C Wolfe, LMFT - Couples Therapy in Arlington, MA

Howard C Wolfe, LMFT is a Marriage & Family Therapist based in Arlington, Massachusetts. Howard C Wolfe is licensed to practice in Massachusetts (license number 118) and his current practice location is 7 Central Street, Suite 211, Arlington, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (781) 643-7272.

NPI number for Howard C Wolfe is 1831392091 and his current mailing address is 7 Central Street, Suite 211, Arlington, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1831392091.

Contact Information

Howard C Wolfe, LMFT
7 Central Street, Suite 211,
Arlington, MA 02476
(781) 643-7272
(866) 206-6346

Healthcare Provider's Profile

Full NameHoward C Wolfe
GenderMale
SpecialityMarriage & Family Therapist
Location7 Central Street, Arlington, Massachusetts
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1831392091
  • Provider Enumeration Date: 06/06/2007
  • Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Howard C Wolfe such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1831392091NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
106H00000XMarriage & Family Therapist 118 (Massachusetts)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Howard C Wolfe is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Howard C Wolfe, LMFT
7 Central Street, Suite 211,
Arlington, MA 02476

Ph: (781) 643-7272
Howard C Wolfe, LMFT
7 Central Street, Suite 211,
Arlington, MA 02476

Ph: (781) 643-7272

News Archive

AMRI initiates enrollment for Phase I study of ALB-127158 for obesity

AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.

ID Biomedical awarded US$9.5 million to develop its cell culture-based influenza vaccine

ID Biomedical announced today that it has been awarded a US$9.5 million grant from the U.S. National Institutes of Health (NIH) to develop its cell culture-based influenza vaccine.

People with BPD traits have lowered activity in brain regions that support empathy

Those with borderline personality disorder, or BPD, a mental illness marked by unstable moods, often experience trouble maintaining interpersonal relationships. New research from the University of Georgia indicates that this may have to do with lowered brain activity in regions important for empathy in individuals with borderline personality traits.

Unigene enters agreement with GSK to advance oral PTH Phase 2 program for osteoporosis

Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.

Protein Hydrogels Can be Genetically Engineered to Promote

Johns Hopkins University researchers have created a new class of artificial proteins that can assemble themselves into a gel and encourage the growth of selected cell types. This biomaterial, which can be tailored to send different biological signals to cells, is expected to help scientists who are developing new ways to repair injured or diseased body parts.

Read more News

› Verified 4 days ago


Marriage & Family Therapist in Arlington, MA

Richard Adam Russell, LMFT
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 29 Claremont Ave., Arlington, MA 02476
Phone: 857-576-2742    
Ms. Suzanne Elizabeth Marcus, M.A.,L.M.F.T.
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 94 Pleasant St, Arlington, MA 02476
Phone: 781-643-4336    
Ms. Mary Catherine Ward, MSW
Couples Therapy
Medicare: Accepting Medicare Assignments
Practice Location: 742 Massachusetts Ave, Arlington, MA 02476
Phone: 781-472-0884    
Ms. Ulrike Dettling, M.A., L.M.F.T.
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 366 Mass Ave, #304, Arlington, MA 02474
Phone: 781-648-9334    Fax: 781-648-9334

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.